"GLP-1 drugs"

A new survey from the healthcare policy think tank KFF reveals that nearly 1 in 8 adults in the United States has turned to GLP-1 drugs such as Ozempic or …

A recent report from the FDA’s Adverse Event Reporting System (FAERS) has linked weight loss drugs like Ozempic and Wegovy to 162 deaths in the U.S. over the past six …

The House Ways and Means Committee advanced four bills on Thursday, aiming to allow Medicare to cover weight-loss drugs for certain beneficiaries.  The vote, which passed 36-4, is a crucial …

President Donald Trump announced agreements with Eli Lilly and Novo Nordisk that will sharply lower the cost of popular weight-loss drugs.  The deals will make medications such as Wegovy and …

A recent analysis published in The Lancet reveals a sobering outlook for life expectancy in the United States over the coming decades.  According to forecasts by the University of Washington’s …

A recent study from Case Western Reserve University in Cleveland, Ohio, suggests that the diabetes drug Ozempic and other semaglutide medications may significantly reduce the risk of Alzheimer’s disease in …

Recent research has shown that Wegovy and Ozempic, two popular weight-loss drugs, may reduce the risk of several obesity-related cancers.  The findings, published in the July 5 issue of JAMA …

For the first time in over a decade, U.S. obesity rates have declined, suggesting a possible shift in a long-standing public health concern.  According to a study published in JAMA …

In the next 25 years, nearly 260 million Americans could be overweight or obese by 2050, according to a new study published in The Lancet.  Researchers from the Institute for …